USANA Health Sciences, Inc. (USNA) Tops Q3 EPS by 5c, Raises FY11 Guidance
USANA Health Sciences, Inc. (NASDAQ: USNA) reported Q3 EPS of $0.81, $0.05 better than the analyst estimate of $0.76. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $142.3 million.
USANA Health Sciences, Inc. sees FY2011 EPS of $3.20-$3.25, versus prior guidance of $3.05-$3.10 and the consensus of $3.10. USANA Health Sciences, Inc. sees FY2011 revenue of $577-$581 million, versus prior guidance of $565-$575 million and the consensus of $578.03 million.
USANA Health Sciences, Inc. sees FY2011 EPS of $3.20-$3.25, versus prior guidance of $3.05-$3.10 and the consensus of $3.10. USANA Health Sciences, Inc. sees FY2011 revenue of $577-$581 million, versus prior guidance of $565-$575 million and the consensus of $578.03 million.